Thioredoxin Reduces Post-Ischemic Myocardial Apoptosis by Blocking ONOO-- Induced Protein Nitration

TAO Ling,ZANG Yi-min,Liu Hui-rong,GAO Feng,Ma Xin-liang

DOI: https://doi.org/10.3969/j.issn.1004-0188.2005.03.003

2005-01-01

Abstract:To determine the mechanism responsible for thioredoxin(Trx )cardioprotective effect. Method: Adult male mice were subjected to 30 min of myocardial ischemia (MI) followed by 3 h reperfusion(R). Mice were randomized to receive vehicle (PBS)or human Trx(hTrx,2 mg/kg, ip.) 10 min before R. At the end of the reperfusion period, the animal heart was quickly excised, and the ischemic/reperfused cardiac tissue was isolated. The levels of myocardial apoptosis and nitrotyrosine were determined 3 h after R. Results: Treatment with hTrx before R decreased significantly post-ischemic myocardial apoptosis (p ＜0.01). Moreover, the level of cardiomyocyte protein nitration represented by nitrotyrosine reduced markedly in animals treated with Trx (4.8±0.53 vs. 9.5±0.86 pmol/mg protein, p ＜0.01), which suggests that Trx may exert its cardioprotective effect by blocking protein nitration and subsequent apoptosis. To further demonstrate a causative-link between the anti-nitrative and cardioprotective effect of Trx, peroxynitrite was added in cultured adult cardiomyocytes and the effect of Trx on peroxynitrite-induced apoptosis were determined. Incubation of cardiomyocytes with SIN-1 (50 μmol, a peroxynitrite donor) for 3 h caused significant cardiomyocyte apoptosis (P＜0.01). Treatment with Trx decreased markedly apoptosis induced by SIN-1 (P＜0.01). Conclusion: It is demonstrated that Trx is a novel anti-apoptotic and cardioprotective molecule that exerts its cardioprotective effects by blocking peroxynitrite-induced protein nitration and subsequent apoptosis.